Cellectis (CLLS) FCF Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 43,511.00 |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -10,482.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,482.00 |
| Dec 31, 2025 | -7,344.00 |
| Sep 30, 2025 | 3,008.00 |
| Jun 30, 2025 | -72,001.00 |
| Mar 31, 2025 | 35,275.00 |
| Dec 31, 2024 | -1.51 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Sep 30, 2023 | 379,991.00 |
| Jun 30, 2023 | -881,335.00 |
| Mar 31, 2023 | -1.98 Mn |
| Sep 30, 2022 | -1.43 Mn |
| Jun 30, 2022 | -167,356.00 |
| Mar 31, 2022 | -35,184.00 |
| Sep 30, 2021 | 136.00 |
| Jun 30, 2021 | 22,458.00 |
| Mar 31, 2021 | -6,179.00 |
| Dec 31, 2020 | -8,835.00 |
| Sep 30, 2020 | -10,947.00 |
| Jun 30, 2020 | 129,694.00 |
| Mar 31, 2020 | 200,576.00 |
| Dec 31, 2019 | 217,564.00 |
| Sep 30, 2019 | 131,842.00 |
| Jun 30, 2019 | -134,372.00 |
| Mar 31, 2019 | -166,680.00 |
| Dec 31, 2018 | -266,611.00 |
| Sep 30, 2018 | -127,736.00 |
| Jun 30, 2018 | 1,487.00 |
| Mar 31, 2018 | -8,664.00 |
| Dec 31, 2017 | 10,081.00 |
| Sep 30, 2017 | -24,859.00 |
| Jun 30, 2017 | 93,654.00 |
| Mar 31, 2017 | -4,785.00 |
| Dec 31, 2016 | -37,808.00 |
| Sep 30, 2016 | 6,326.00 |
| Jun 30, 2016 | -97,372.00 |
| Mar 31, 2016 | -20,388.00 |